Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India

    Mary Theresa Sylvia, Biswajit Dey, Debdatta Basu, Sajini Elizabeth Jacob, Rakhee Kar, Biswajit Dubashi
    e2016060
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.060
    3223
    PDF: 786
    HTML: 2972
    Figure 1a and 1b: 153
    Figure 2: 163
    Figure 3: 181
    Figure 4: 164
    Figure 5: 167
    Tables 1-5: 156
  • CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL

    Ugo Testa, Prof. Sica, Dr. Pelosi, Dr. Germana Castelli, Prof. Leone
    e2024010
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.010
    4308
    PDF: 3550
    HTML: 220
  • Guest Edtor: Pellegrino Musto NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES

    Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia, Antonella Poloni, Massimo Offidani
    e2025027
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.027
    1455
    PDF: 1242
    HTML: 278
  • LIVER IRON CONTENT IN INDIVIDUALS WITH LIVER IRON CONTENT IN INDIVIDUALS WITH Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS.: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS. Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA

    Alberto Piperno
    e2026051
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.051
    141
    PDF: 74
    Suppl. Files: 12
    HTML: 1
  • BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

    Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli
    e2016011
    2016-02-10
    https://doi.org/10.4084/mjhid.2016.011
    4357
    PDF: 1491
    HTML: 3627
  • TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo
    e2025039
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.039
    2296
    PDF: 1641
    HTML: 276
  • Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature

    Jayastu Senapati, Anup J Devasia, Abhijeet Ganapule, Leni George, Auro Viswabandya
    e2014016
    2014-02-17
    https://doi.org/10.4084/mjhid.2014.016
    1996
    PDF: 921
    HTML: 1770
    Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 169
  • TREOSULFAN-BASED CONDITIONING REGIMEN IN SIBLING AND ALTERNATIVE DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH SICKLE CELL DISEASE

    Antonio Marzollo, Elisabetta Calore, Manuela Tumino, Marta Pillon, Maria Vittoria Gazzola, Roberta Destro, Raffaella Colombatti, Piero Marson, Tiziana Tison, Anna Colpo, Chiara Mainardi, Maria Gabelli, Maria Paola Boaro, Sara Rossin, Aurora Strano, Nadia Quaglia, Federica Menzato, Giuseppe Basso, Laura Sainati, Chiara Messina
    e2017014
    2017-02-15
    https://doi.org/10.4084/mjhid.2017.014
    4322
    PDF: 1530
    HTML: 1192
  • SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW

    Francesca Pavanello, Sara Steffanoni, Michele Ghielmini, Emanuele Zucca
    e2016062
    2016-11-06
    https://doi.org/10.4084/mjhid.2016.062
    3781
    PDF: 1071
    HTML: 2059
  • CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,

    Ugo Testa, Giuseppe Leone, Elvira Pelosi, Dr. Germana Castelli, Prof. Hohaus
    e2023066
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.066
    3746
    PDF: 1469
    HTML: 188
  • INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY

    Giuseppe Leone, Livio Pagano
    e2018039
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.039
    4221
    PDF: 1463
    HTML: 611
  • SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs

    Massimo Breccia, Giuliana Alimena
    e2014003
    2014-01-02
    https://doi.org/10.4084/mjhid.2014.003
    3287
    PDF: 1227
    HTML: 3475
  • INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    AnnaMaria Nosari
    e2012070
    2012-11-05
    https://doi.org/10.4084/mjhid.2012.070
    3348
    PDF: 1367
    HTML: 2674
  • Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis

    Marianna Criscuolo, Luana Fianchi, Patrizia Chiusolo, Simona Sica, Livio Pagano
    e2026060
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.060
    1942
    PDF: 71
    HTML: 20
  • FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.

    Andrea Gallamini, Anna Borra
    e2017029
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.029
    3333
    PDF: 1251
    HTML: 2209
  • Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab

    Ruben Fernandez, Esther Gonzalez, Almudena Fernandez, Ana Pilar Gonzalez, Juan Manuel Sancho, Francisco Dominguez, Carmen Fernandez
    e2014017
    2014-02-16
    https://doi.org/10.4084/mjhid.2014.017
    1628
    PDF: 891
    HTML: 3159
    Figure 5: 158
    Figure 4: 159
    Figure 3: 194
    Figure 1: 174
    Figure 2: 170
  • CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.

    Luca Laurenti, Barbara Vannata, Idanna Innocenti, Francesco Autore, Francesco Santini, Nicola Piccirillo, Tommaso Za, Silvia Bellesi, Sara Marietti, Simona Sica, Dimitar G. Efremov, Giuseppe Leone
    e2013031
    2013-05-01
    https://doi.org/10.4084/mjhid.2013.031
    3253
    PDF: 913
    HTML: 1543
    Fig.1 CHL-R paper: 226
    Fig 2 CHL-R paper: 246
  • CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES

    Ugo Testa, Prof. Patrizia Chiusolo, Dr. Elvira Pelosi, Dr. Germana Castelli, Giuseppe Leone
    e2024031
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.031
    2223
    PDF: 2056
    HTML: 199
  • EFFICACY AND SAFETY OF THALIDOMIDE IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA: A SYSTEMATIC REVIEW, META-ANALYSIS AND GRADE EVALUATION

    Jialian Li, Ping Ji, Qinyue Zhong, Lin Dong, Hai Yi, Baiyu Chen, Xu Zhang, Tingting Duan
    e2026033
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.033
    244
    PDF: 249
    Suppl. Files: 42
    HTML: 19
  • DAYS ALIVE OUTSIDE HOSPITAL AND RE-ADMISSIONS IN PATIENTS UNDERGOING ALLOGENEIC TRANSPLANTS FROM IDENTICAL SIBLINGS, UNRELATED DONORS OR HAPLOIDENTICAL DONORS “.

    Federica Sorà, patrizia chiusolo, luca laurenti, idanna innocenti, francesco autore, sabrina giammarco, elisabetta metafuni, eleonora alma, alessia di giovanni, simona sica, andrea bacigalupo
    e2020055
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.055
    1222
    PDF: 688
    HTML: 312
  • CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment

    Ugo Testa, Elvira Pelosi, Dr. Germana Castelli
    e2024077
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.077
    1756
    PDF: 854
    HTML: 152
  • THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT

    Paul Richardson, Jacob Laubach, Anuj Mahindra, Constantine Mitsiades, Robert Schlossman, Irene Ghobrial, Teru Hideshima, Noopur Raje, Nikhil Munshi, Kenneth Anderson
    e2010009
    2010-05-03
    https://doi.org/10.4084/mjhid.2010.009
    1118
    PDF: 724
    HTML: 621
  • IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Franco Aversa, Lucia Prezioso, Ilenia Manfra, Federica Galaverna, Angelica Spolzino, Alessandro Monti
    e2016057
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.057
    4373
    PDF: 1120
    HTML: 1428
  • HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

    Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré
    e2014050
    2014-07-01
    https://doi.org/10.4084/mjhid.2014.050
    2921
    PDF: 1374
    HTML: 3578
    Untitled: 196
    Untitled: 211
    Untitled: 184
  • TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin

    Cristina Papayannidis, Vincenzo Federico, Luana Fianchi, Patrizia Pregno, Novella Pugliese, Alessandra Romano, Federica Irene Grifoni
    e2022073
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.073
    1265
    PDF: 1016
    HTML: 225
  • CLASSICAL HODGKIN LYMPHOMA TODAY

    Francesco D'Alò, Gabriele Schiaffini, Daniele Mazzoni, Eleonora Alma, Flaminia Bellisario, Marcello Viscovo, Elena Maiolo, Silvia Bellesi, Stefan Hohaus
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.055
    300
    PDF: 146
    HTML: 35
  • PLASMA CELL LEUKEMIA UPDATE ON IMMUNOPHENOTYPE, MOLECULAR CHARACTERISTICS, AND THERAPY. The second part of plasma cell neoplasms with spreading in the blood and tissues Plasma Cell Leukemia

    Giuseppe G.M. Leone, Ugo Testa
    e2025080
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.080
    1361
    PDF: 377
    Html: 132
  • THE COURSE OF HEPATITIS C INFECTION AND RESPONSE TO ANTI-VIRAL THERAPY IN PATIENTS WITH THALASSEMIA MAJOR AND HEPATITIS C INFECTION: A LONGITUDINAL, PROSPECTIVE STUDY.

    Sanaa Kamal, Sara Abdelhakam, Dr., Dahlia Ghoraba, Mohamad Amer Mohsen, Ahmed Abdelsalam, Huda Hassan, Leila Nabeigh
    e2019060
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.060
    1388
    PDF: 1050
    HTML: 211
  • IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.

    Jean Elcheikh
    e2013026
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.026
    1316
    PDF: 745
    HTML: 1430
  • Long-term persistence of dysplastic features in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide

    Enrico Santinelli, Maria Rosaria Pascale, Luca Guarnera, Arianna Savi, Flavia Mallegni, Carmelo Gurnari, Luca Maurillo, Maria Teresa Voso, Susanna Fenu
    e2025038
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.038
    1047
    PDF: 750
    HTML: 90
  • LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE

    Patrizia Tosi
    e2013037
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.037
    1315
    PDF: 912
    HTML: 1281
    fig 1A: 177
    figure1B: 152
  • FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT

    Alessia Castellino, Umberto Vitolo
    e2017009
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.009
    4452
    PDF: 1649
    HTML: 4050
    Tables and Images: 232
  • WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE

    Maddalena Mazzucchelli, Anna Maria Frustaci, Marina Deodato, Roberto Cairoli, Alessandra Tedeschi
    e2018004
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.004
    7660
    PDF: 2446
    HTML: 1740
    Table 1.: 214
    Table 2.: 224
    Table 3.: 208
    Table 4.: 209
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 2- FOCUS ON THERAPY

    Michele Bibas, Shayna Sarosiek , Jorge Castillo
    e2025015
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.015
    2582
    PDF: 2034
    HTML: 221
  • Does splenectomy influence the development of Hypothyroidism in Transfusion Dependent Thalassemia Patients? A retrospective study. Splenectomy in Hypothyroidism of TDT patients

    Christos KATTAMIS, Myrto Skafida, Christalena Sofocleous, Antonis Kattamis
    e2019064
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.064
    1247
    PDF: 969
    HTML: 312
  • FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL

    Muhammad Imran Hasan Khan, Eram Anwar, Adnan Agha, Noha Saleh, Ehsan Ullah, Imran Ali Syed, Arsalan Raja
    e2013014
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.014
    2456
    HTML: 9400
    DOCX: 1013
    Tables Dengue: 211
  • HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PAEDIATRIC PATIENTS WITH X-LINKED LYMPHOPROLIFERATIVE SYNDROME

    Yuan Sun
    e2024036
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.036
    1334
    PDF: 1176
    HTML: 172
  • Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia

    Tathagata Chatterjee, Srishti Gupta, Ajay Sharma, Sanjeevan Sharma, Devika Gupta
    e2013042
    2013-06-04
    https://doi.org/10.4084/mjhid.2013.042
    3170
    PDF: 978
    HTML: 3137
    flowcytometric result of peripheral blood sample: 185
  • GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey

    Mehmet Hilmi DOGU, Ali Irfan Emre TEKGUNDUZ, Burak DEVECI, Gulten KORKMAZ, Melda COMERT, Omur Gokmen SEVINDIK, Osman YOKUS, Istemi SERIN
    e2023031
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.031
    1462
    PDF: 915
    Suppl. Files: 457
    HTML: 245
  • ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

    Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko
    e2018014
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.014
    5290
    PDF: 1939
    HTML: 1365
  • FLUDARABINE-BASED LOW-INTENSITY CONDITIONING FOR FANCONI ANEMIA IS ASSOCIATED WITH GOOD OUTCOMES IN APLASTIC ANEMIA BUT NOT IN MDS - A SINGLE-CENTER EXPERIENCE

    Biju George, Sohini Chattopadhyay, Sharon Lionel, Sushil Selvarajan, Anup Devasia, Anu Korula, Uday Kulkarni, Fouzia Aboobacker, Eunice Sindhuvi, Kavitha Lakshmi, Alok Srivastava, Aby Abraham, Vikram Mathews
    e2023039
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.039
    1343
    PDF: 1011
    HTML: 330
  • ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULT PATIENTS WITH FANCONI ANEMIA.

    hosein kamranzadeh fumani, Mohammad Zokaasadi, Amir Kasaeian, Kamran Alimoghaddam, Asadollah Mousavi, Babak Bahar, Mohammad Vaezi, Ardeshir Ghavamzadeh
    e2016054
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.054
    3954
    PDF: 878
    HTML: 737
  • CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL

    Ugo Testa, Dr. Elvira Pelosi, Dr. Germana Castelli, Dr. Alberto Fresa, Prof. Luca Laurenti
    e2024045
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.045
    3710
    PDF: 1624
    HTML: 80
  • INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISORDERS IN THE ERA OF TARGET DRUGS

    Livio Pagano, Davide Facchinelli, Dr.
    e2018063
    2018-10-27
    https://doi.org/10.4084/mjhid.2018.063
    2073
    PDF: 1124
    HTML: 228
  • FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA.

    Daniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, Varun Mehra, Pramila Krishnamurthy, Francesco Dazzi, Ye Ting Leung, Sandra Anteh, Mili Naresh Shah, Andrea Kuhnl, Robin Sanderson, Piers Patten, Deborah Yallop, Antonio Pagliuca, Victoria Potter
    e2023041
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.041
    1624
    PDF: 728
    HTML: 223
  • IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma

    Hongfeng Wang, Jianbin Chen
    e2026062
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.062
    67
    PDF: 70
    HTML: 4
  • ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS

    Alessandro Busca, Livio Pagano
    e2016039
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.039
    4793
    PDF: 1568
    HTML: 2251
    Untitled: 217
    Untitled: 233
    Untitled: 237
    Untitled: 223
    Untitled: 224
  • HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.

    Daniele Avenoso, Fabio Serpenti, Liron Barnea Slonim, Styliani Bouziana, Francesco Dazzi, Guy Hannah, Michelle Kenyon, Varun Mehra, Austin Kulasekararaj, Pramila Krishnamurthy, Mili Naresh Shah, Sharon Lionel, Antonio Pagliuca, Victoria Potter
    e2024002
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.002
    1354
    PDF: 1450
    HTML: 155
  • Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

    Nathalia Sena de Oliveira Silva, Gislaine Duarte, Samuel de Souza Medina, Guilherme Brasil Duffles Amarante, Carmino Antonio de Souza, Katia Borgia Barbosa Pagnano
    e2026001
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.001
    689
    PDF: 513
    Html: 96
  • Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients

    Gianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Cinzia Pellegrini, Beatrice Casadei, Francesca Bonifazi, Pier Luigi Zinzani
    e2024004
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.004
    1457
    PDF: 1413
    HTML: 194
1 - 50 of 240 items 1 2 3 4 5 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.